Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Oncotarget
|
April 18, 2018
Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features
Rebeca Manso, Julia González-Rincón, Manuel Rodríguez-Justo, et al.
Plos One
|
May 16, 2017
Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines
Rufino Mondejar, Cristina Pérez, Arantza Onaindia, et al.
Hematological Oncology
|
March 7, 2019
Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group
Miriam Méndez, Maria Torrente, Margarita Sánchez-Beato, et al.
Oncotarget
|
December 22, 2017
Mutational profile of primary breast diffuse large B-cell lymphoma
Fernando Franco, Julia González-Rincón, Javier Lavernia, et al.
Scientific Reports
|
February 1, 2019
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Julia González-Rincón, Sagrario Gómez, Nerea Martinez, et al.
Scientific Reports
|
January 22, 2021
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma
Lucía Pedrosa, Ismael Fernández-Miranda, David Pérez-Callejo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 19, 2024
Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma
Ismael Fernández-Miranda, Lucía Pedrosa, Julia González-Rincón, et al.
Plos One
|
February 26, 2019
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
Julia González-Rincón, Miriam Méndez, Sagrario Gómez, et al.
Plos One
|
September 10, 2021
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
Julia González-Rincón, José A Garcia-Vela, Sagrario Gómez, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Oncotarget
|
April 18, 2018
Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features
Rebeca Manso, Julia González-Rincón, Manuel Rodríguez-Justo, et al.
Plos One
|
May 16, 2017
Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines
Rufino Mondejar, Cristina Pérez, Arantza Onaindia, et al.
Hematological Oncology
|
March 7, 2019
Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group
Miriam Méndez, Maria Torrente, Margarita Sánchez-Beato, et al.
Oncotarget
|
December 22, 2017
Mutational profile of primary breast diffuse large B-cell lymphoma
Fernando Franco, Julia González-Rincón, Javier Lavernia, et al.
Scientific Reports
|
February 1, 2019
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Julia González-Rincón, Sagrario Gómez, Nerea Martinez, et al.
Scientific Reports
|
January 22, 2021
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma
Lucía Pedrosa, Ismael Fernández-Miranda, David Pérez-Callejo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 19, 2024
Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma
Ismael Fernández-Miranda, Lucía Pedrosa, Julia González-Rincón, et al.
Plos One
|
February 26, 2019
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
Julia González-Rincón, Miriam Méndez, Sagrario Gómez, et al.
Plos One
|
September 10, 2021
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
Julia González-Rincón, José A Garcia-Vela, Sagrario Gómez, et al.
Page
of 1